Long-term follow-up of patients with relatively high effective defibrillation threshold during cardioverter defibrillator implantation with endocardial leads

Cardiology

Volumn 112, Issue 2, 2008, Pages 107-113

  Rosenheck, Shimon ^a   Sharon, Zehava ^a   Weiss, Alexey ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Defibrillation efficacy evaluation; Defibrillation threshold; Implantable cardioverter defibrillator

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DEFIBRILLATION; DEFIBRILLATION THRESHOLD; DEFIBRILLATOR; ENDOCARDIUM; FEMALE; FOLLOW UP; HEART PACING; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT SAFETY; PRIORITY JOURNAL; SURVIVAL;

ADULT; AGED; DEFIBRILLATORS, IMPLANTABLE; DISEASE-FREE SURVIVAL; ELECTRODES, IMPLANTED; ENDOCARDIUM; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; STROKE VOLUME; VENTRICULAR FIBRILLATION;

EID: 55349104568     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000141463     Document Type: Article

References (27)

1. Mirowski M, Ried PR, Mower MM, Watkins L, Gott VL, Schauble JF, Langer A, Heilman MS, Kolenik SA, Fischell RE, Weisfeldt ML: Termination of malignant ventricular arrhythmia with an implanted automatic defibrillator in human beings. N Engl J Med 1980;303:322-324.
2. Mirowski M: The automatic implantable cardioverter-defibrillator. J Am Coll Cardiol 1985;6:461-466.
3. Josephson ME, Callans DJ, Buxton AE: The role of implantable cardioverter-defibrillator for prevention of sudden cardiac death. Ann Intern Med 2000;133:901-910.
4. Goldberger Z, Lampert R: Implantable cardioverter-defibrillators. Expending indications and technology. JAMA 2006;295:809-818.
5. Tandri H, Griffith LS, Tang T, Nasir K, Zardkoohi O, Reddy CV, Capps M, Calkins H, Donahue JK: Clinical course and long-term follow-up of patients receiving implantable cardioverter-defibrillators. Heart Rhythm 2006;3:762-768.
6. Myerburg RJ, Castellanos A: A unique historical overview of the implantable cardioverter-defibrillator. Heart Rhythm 2006;3:169-170.
7. Bardy GH, Ivey TD, Allen MD, Johnson G, Mehra R, Greene HL: A prospective randomized evaluation of biphasic versus monophasic waveform pulses on defibrillation efficacy in human. J Am Coll Cardiol 1989;14:728-733.
8. Morris MM, KenKnight BH, Warren JA, Lang DJ: A preview of implantable cardioverter defibrillator systems in the next millennium; an integrative cardiac rhythm management approach. Am J Cardiol 1999;83:49D-54D.
9. Bardy GH, Johnson G, Poole JE, Dolack GL, Kudenchuk PJ, Kelso D, Mitchell R, Mehra R, Hofer B: A simplified, single-lead unipolar transvenous cardioversion-defibrillation system. Circulation 1993;88:543-547.
10. Gold MR, Foster AH, Shorofsky SR: Effects of an active pectoral-pulse generator shell on defibrillation efficacy with a transvenous lead system. Am J Cardiol 1996;78:540-543.
11. Venditti FJ, Martin DT, Vassolas G, Bowen S: Rise in chronic defibrillation thresholds in nonthoracotomy implantable defibrillator. Circulation 1994;89:216-223.
12. Shukla HH, Flaker GC, Jayam V, Roberts D: High defibrillation threshold in transvenous biphasic implantable defibrillators: clinical predictors and prognostic implications. Pacing Clin Electrophysiol 2003;26:44-48.
13. Mainigi SK, Callans DJ: How to manage the patient with high defibrillation threshold. Heart Rhythm 2006;3:492-495.
14. Mainigi SK, Cooper JM, Russo AM, Nayak HM, Lin D, Dixit S, Gerstenfeld EP, Hisia HH, Callans DJ: Elevated defibrillation thresholds in patients undergoing biventricular defibrillator implantation: incidence and predictors. Heart Rhythm 2006;3:1010-1016.
15. Day JD, Doshi RN, Bellot P, et al: Induction or limited shock testing is possible in most patients with implantable cardioverter-defibrillator/ cardiac resynchronization therapy defibrillators. Results of a multicenter ASSURE study. Circulation 2007;115:2382-2389.
16. Strickberger SA, Klein GJ: Is defibrillation testing required for defibrillator implantation? J Am Coll Cardiol 2004;44:88-91.
17. Stevenson WG, Chaitman BR, Ellenbogen KA, Epstein AE, Gross WL, Hayes DL, Strickberger SA, Sweeney MO: Clinical assessment of patients with implantable cardioverter defibrillators presenting to nonelectrophysiologists. Circulation 2004;110:3866-3869.
18. Fotuhi PC, Epstein AE, Ideker RE: Energy levels for defibrillation: what is of real clinical importance? Am J Cardiol 1999;83:24D-33D.
19. Kroll MW, Tchou PJ: Testing of implantable defibrillator function at implantation; in Ellenbogen KA, Kay GN, Wilkoff BC (eds): Clinical Cardiac Pacing and Defibrillation, ed 2. Philadelphia, WB Saunders, 2000, pp 540-561.
20. Winkle RA, Thomas A: The automatic implantable cardioverter defibrillator: the US experience; in Brugada P, Wellens HJJ (eds): Cardiac Arrhythmias: Where to Go from Here? New York, Futura Publishing Co Inc, 1987, pp 663-680.
21. Rosenthal ME, Josephson ME: Current status of antitachycardia devices. Circulation 1990;82:1889-1899.
22. Saksena S, Personnet V: Implantation of a cardioverter/defibrillator without thoracotomy using a triple electrode system. JAMA 1988;259:69-72.
23. Yee R, Klein GJ, Leitch JW, Guiraudon GM, Guiraudon CM, Jones DL, Norris C: A permanent transvenous lead system for an implantable pacemaker cardioverter-defibrillator. Nonthoracotomy approach to implantation. Circulation 1992;85:196-204.
24. Marchlinski FE, Flores B, Miller JM, Gottlieb CD, Hargrove WC 3rd: Relation of intraoperative defibrillation threshold to successful postoperative defibrillation with automatic implantable cardioverter defibrillator. Am J Cardiol 1988;62:393-398.
25. Swerdlow CD: Reappraisal of implant testing of implantable cardioverter defibrillators. J Am Coll Cardiol 2004;44:92-94.
26. Russo AM, Sauer W, Gerstenfeld EP, Hsia HH, Lin D, Cooper JH, Dixit S, Verdino RJ, Nayak HM, Callans DJ, Patel V, Marchlinski FE: Defibrillation threshold testing: is it really necessary at the time of implantable cardioverter-defibrillator insertion? Heart Rhythm 2005;2:456-461.
27. Pires LA, Johnson KM: Intraoperative testing of the implantable cardioverter-defibrillator: how much is enough? J Cardiovasc Electrophysiol 2006;17:140-145.